Material deemed appropriate for presentation before the International Society for Minimally Invasive Cardiothoracic Surgery will have the following characteristics:
Submitters should avoid abbreviations as much as possible. When abbreviations are necessary. authors must define them at first mention in text, and in each table and figure. If a brand name is cited, supply the manufacturer's name and address (city, state, country).
One table (submitted as a Word document) or figure may be used within your abstract. Digital art should be created/scanned, saved and submitted as a TIFF, PowerPoint or JPEG. Electronic photographs, CT scans, and scanned images must have a resolution of at least 300 dpi (dots per inch). Line art must have a resolution of at least 1200 dpi. Do not add any lettering to the figures.
Include a title for the table, and a legend for each figure in the provided box. Cite figures consecutively in the text, and number them in the order in which they are discussed.
Do not use trademark or registry symbols: TM or R in the litle, the text of the abstract, or on tables/figures.
Avoid spelling mistakes, as the abstracts will be published as you have submitted.
No reference should be made on or in the abstract to the names or institutions of the authors.
To comply with the Standards of Commercial Support of the Accreditation Council for Continuing Medical Education (ACCME). Product names may not be included in the title or body of the abstract, or the abstract may be disqualified. Please use generic, non-commercial, names for all therapeutic agents.
Accepted abstracts will be published in the official ISMICS journal, INNOVATIONS, as submitted.
Acceptance of an abstract by the Program Committee for oral or video presentation at the Annual Meeting signifies the author(s) have given permission, pending editorial review, for this abstract to be reproduced in the official ISMICS professional journal and available on the ISMICS website.
If the abstract is accepted for oral or poster competition presentation at the meeting, manuscript submission to Innovations is REQUIRED by May 30, 2026.
Decisions of the Program Committee will be made known to all Presenting Authors by email after the first week of February 2026. It is the responsibility of the Presenting Author to notify all co-authors of the Program Committee's decision.